Document is current
Any future updates will be listed below
-
Authors
Ebbert, Mark T. W.
Jensen, Tanner D.
Jansen-West, Karen
Sens, Jonathon P.
Reddy, Joseph S.
Ridge, Perry G.
Kauwe, John S. K.
Belzil, Veronique
Pregent, Luc
Carrasquillo, Minerva M.
Keene, Dirk
Larson, Eric
Crane, Paul
Asmann, Yan W.
Ertekin-Taner, Nilufer
Younkin, Steven G.
Ross, Owen A.
Rademakers, Rosa
Petrucelli, Leonard
Fryer, John D.
-
Funding
Funding for this research was provided by:
PhRMA Foundation (RSGTMT17)
Florida Department of Health (8AZ10, 9AZ08, 6AZ06)
Muscular Dystrophy Association
National Institute of Neurological Disorders and Stroke (NS094137, NS097261, NS097273, NS084528, NS084974, NS099114, NS088689, NS093865)
National Institute on Aging (AG047327, AG049992)
U.S. Department of Defense (AL130125)
Mayo Clinic Foundation
Mayo Clinic Center for Individualized Medicine
Amyotrophic Lateral Sclerosis Association
Robert Packard Center for ALS Research, Johns Hopkins University
Target ALS
Association for Frontotemporal Degeneration
GHR Foundation
Mayo Clinic Gerstner Family Career Development Award
- License Information
-
More Information
Article History
Received: 21 December 2018
Accepted: 6 May 2019
First Online: 20 May 2019
Ethics approval and consent to participate
: The Mayo Clinic Institutional Review Board (IRB) approved all procedures for this study, and we followed all appropriate protocols. All participants included in this study provided written informed consent, and all experimental methods comply with the Helsinki Declaration.
: All participants were properly consented for this study.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
